Taro: Sun Pharma to acquire Taro’s 100% stake in all-cash – Times of India
[ad_1] MUMBAI: India’s biggest drug maker Sun Pharma has offered to acquire the outstanding shareholding in its US subsidiary, Taro Pharma for around $300 million through a reverse triangular merger.In the all cash deal, Sun Pharma will acquire the shares at a price of US $38 per ordinary share, which will be payable in full … Read more